| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M512227200 |
| P8608 | Fatcat ID | release_olzwnwmb4vhotjyad5nwbjlgy4 |
| P698 | PubMed publication ID | 16407288 |
| P50 | author | Richard Weinshilboum | Q52447985 |
| P2093 | author name string | Daniel J Schaid | |
| Liewei Wang | |||
| Eric D Wieben | |||
| Bruce W Eckloff | |||
| Bianca A Thomae | |||
| Baidehi Mukherjee | |||
| Annette F Klumpp | |||
| Oreste E Salavagionne | |||
| Thomas C Wood | |||
| P2860 | cites work | Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype | Q42665811 |
| Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation | Q44584264 | ||
| Evaluation of toxicity of the pesticides, chlorpyrifos and arsenic, in the presence of compost humic substances in aqueous systems | Q44625110 | ||
| Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: functional genetic polymorphism | Q44658066 | ||
| Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes | Q44765959 | ||
| Human phenylethanolamine N-methyltransferase pharmacogenomics: gene re-sequencing and functional genomics | Q46513885 | ||
| Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics | Q46748519 | ||
| Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells | Q56114256 | ||
| Arsenic and atherosclerosis | Q23919496 | ||
| Consed: a graphical tool for sequence finishing | Q27860740 | ||
| Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism | Q28273300 | ||
| Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes | Q28368167 | ||
| A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol | Q28584169 | ||
| Score tests for association between traits and haplotypes when linkage phase is ambiguous | Q29616281 | ||
| PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing | Q29618564 | ||
| Arsenic toxicity, mutagenesis, and carcinogenesis--a health risk assessment and management approach. | Q30339021 | ||
| Computer Programmes for Processing Enzyme Kinetic Data | Q30859896 | ||
| Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes | Q33891890 | ||
| Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes | Q33938954 | ||
| Methylated trivalent arsenic species are genotoxic | Q33942554 | ||
| In vitro effect of arsenical compounds on glutathione-related enzymes | Q33947670 | ||
| Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. | Q33951760 | ||
| Haplotype variation and linkage disequilibrium in 313 human genes | Q33953585 | ||
| Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver | Q34062420 | ||
| Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism | Q34144158 | ||
| Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype | Q34408642 | ||
| Pharmacogenetics: inherited variation in amino acid sequence and altered protein quantity | Q35744187 | ||
| Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review | Q35846817 | ||
| Beta2-adrenoceptor gene polymorphisms | Q36111843 | ||
| Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. | Q36168779 | ||
| Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness | Q37248530 | ||
| Changes in the chemical speciation of arsenic following ingestion by man | Q39144362 | ||
| Airborne arsenic exposure and excretion of methylated arsenic compounds | Q39144734 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arsenic | Q871 |
| functional genomics | Q1068690 | ||
| genomics | Q222046 | ||
| P304 | page(s) | 7364-7373 | |
| P577 | publication date | 2006-01-06 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies | |
| P478 | volume | 281 |
| Q48027899 | A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. |
| Q50295395 | AS3MT transfers CH3 from AdoMet to arsenite(3-) |
| Q50295397 | AS3MT transfers CH3 from AdoMet to methylarsonite |
| Q37146092 | Analysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysis |
| Q37486703 | Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes. |
| Q41843532 | Arsenate Impact on the Metabolite Profile, Production, and Arsenic Loading of Xylem Sap in Cucumbers (Cucumis sativus L.). |
| Q33988886 | Arsenic (+ 3 oxidation state) methyltransferase and the methylation of arsenicals in the invertebrate chordate Ciona intestinalis |
| Q36691809 | Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. |
| Q28392204 | Arsenic exposure and toxicology: a historical perspective |
| Q91440691 | Arsenic exposure: A public health problem leading to several cancers |
| Q23923854 | Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2·Keap1·Cul3 complex and recruiting Nrf2·Maf to the antioxidant response element enhancer |
| Q28651492 | Arsenic methylation and volatilization by arsenite S-adenosylmethionine methyltransferase in Pseudomonas alcaligenes NBRC14159 |
| Q52604485 | Arsenic-gene interactions and beta-cell function in the Strong Heart Family Study. |
| Q28385553 | Arsenic-induced genotoxicity and genetic susceptibility to arsenic-related pathologies |
| Q42695376 | Association Between Variants in Arsenic (+3 Oxidation State) Methyltranserase (AS3MT) and Urinary Metabolites of Inorganic Arsenic: Role of Exposure Level. |
| Q28386218 | Association between polymorphisms in arsenic metabolism genes and urinary arsenic methylation profiles in girls and boys chronically exposed to arsenic |
| Q34023701 | Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions |
| Q35868551 | Biological monitoring and the influence of genetic polymorphism of As3MT and GSTs on distribution of urinary arsenic species in occupational exposure workers |
| Q37444401 | Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study |
| Q33562969 | Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan |
| Q34002472 | Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction |
| Q28397251 | Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure |
| Q45273892 | Effects of selenium on the structure and function of recombinant human S-adenosyl-L-methionine dependent arsenic (+3 oxidation state) methyltransferase in E. coli |
| Q34558657 | Efficient arsenic metabolism--the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT. |
| Q33795368 | Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico. |
| Q37682114 | Frequency of M287T/AS3MT Single Nucleotide Polymorphism in an Iranian Population |
| Q24605527 | From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia |
| Q35923062 | GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh |
| Q24683081 | Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina |
| Q36535101 | Genetic variants associated with arsenic susceptibility: study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes |
| Q36300235 | Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study |
| Q37235645 | Genetic variations associated with interindividual sensitivity in the response to arsenic exposure |
| Q21144927 | Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh |
| Q28396689 | Heritability and preliminary genome-wide linkage analysis of arsenic metabolites in urine |
| Q36089643 | High-throughput screening-compatible assays of As(III) S-adenosylmethionine methyltransferase activity |
| Q37371346 | Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics |
| Q28660913 | Identification of the third binding site of arsenic in human arsenic (III) methyltransferase |
| Q35079230 | Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. |
| Q28395582 | Influence of GSTT1 Genetic Polymorphisms on Arsenic Metabolism |
| Q42705570 | Influence of the level of arsenic (As) exposure and the presence of T860C polymorphism in human As urinary metabolic profile |
| Q40577918 | Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China. |
| Q33823587 | Interspecies differences in metabolism of arsenic by cultured primary hepatocytes |
| Q35044729 | Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity |
| Q36515907 | Linkage Analysis of Urine Arsenic Species Patterns in the Strong Heart Family Study |
| Q39643756 | Manipulation of Expression of Arsenic (+3 Oxidation State) Methyltransferase in Cultured Cells |
| Q35574373 | Mathematical model insights into arsenic detoxification |
| Q27499027 | Mathematical model of uptake and metabolism of arsenic(III) in human hepatocytes - Incorporation of cellular antioxidant response and threshold-dependent behavior |
| Q33699426 | Mathematical modeling of the effects of glutathione on arsenic methylation |
| Q36227529 | Methylation of arsenic by recombinant human wild-type arsenic (+3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: Role of glutathione. |
| Q48108039 | Nonsynonymous Polymorphisms in the Human AS3MT Arsenic Methylation Gene: Implications for Arsenic Toxicity |
| Q34444053 | Pathway of human AS3MT arsenic methylation. |
| Q36522947 | Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase |
| Q34084734 | Polymorphisms and disease: hotspots of inactivation in methyltransferases |
| Q34159791 | Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism |
| Q37423426 | Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics |
| Q36947714 | RNA Sequencing Quantification of Xenobiotic-Processing Genes in Various Sections of the Intestine in Comparison to the Liver of Male Mice. |
| Q34746222 | Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities |
| Q37312651 | SLCO1B1 variants and urine arsenic metabolites in the Strong Heart Family Study. |
| Q27681235 | Structure of an As(III) S -Adenosylmethionine Methyltransferase: Insights into the Mechanism of Arsenic Biotransformation |
| Q38978392 | The organoarsenical biocycle and the primordial antibiotic methylarsenite |
| Q36579671 | shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells |
Search more.